Evidence map›Paper›PMID 30511255›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2019

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.

C Quinten, C Kenis, L Decoster, P R Debruyne, I De Groof, C Focan, F Cornelis, V Verschaeve, C Bachmann, D Bron and 18 more

Abstract read
PubMed Publisher
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Associations of frailty with symptoms, and HRQOL in older cancer survivors after cancer treatments: a systematic review and meta-analyses.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Protein intake, weight loss, dietary intervention, and worsening of quality of life in older patients during chemotherapy for cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Trial
  6. Review
  7. Article
  8. Article
  9. Safety and Efficacy of Pulmonary Rehabilitation for Long COVID Patients Experiencing Long-Lasting Symptoms.International journal of environmental research and public health · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

C QuintenLaboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. chantal.quinten@kuleuven.be.ORCID http://orcid.org/0000-0003-2691-2326
C KenisDepartment of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
L DecosterDepartment of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
P R DebruyneCancer Centre, General Hospital Groeninge, Kortrijk, Belgium & Positive Ageing Research Institute (PARI), Anglia Ruskin University, Chelmsford, UK.
I De GroofDepartment of Geriatric Medicine, Iridium Cancer Network Antwerp, St. Augustinus, Wilrijk, Belgium.
C FocanDepartment of Oncology, Clinique Saint-Joseph, CHC-Liège Hospital Group, Liege, Belgium.
F CornelisDepartment of Medical Oncology, Cliniques Universitaires Saint-Luc, UCL, Brussels, Belgium.
V VerschaeveDepartment of Medical Oncology, GHDC Grand Hôpital de Charleroi, Charleroi, Belgium.
C BachmannDepartment of Geriatric Medicine, AZ Sint-Lucas, Ghent, Belgium.
D BronDepartment of Hematology, ULB Institut Jules Bordet, Brussels, Belgium.
S LuceDepartment Medical Oncology, University Hospital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
G DebugneDepartment of Geriatric Medicine, Centre Hospitalier de Mouscron, Mouscron, Belgium.
H Van den BulckDepartment of Medical Oncology, Imelda Hospital, Bonheiden, Belgium.
J C GoeminneDepartment of Medical Oncology, CHU-UCL-Namur, site Sainte-Elisabeth, Namur, Belgium.
A BaitarDepartment of Medical Oncology, ZNA Middelheim, Antwerp, Belgium.
K GeboersCentre for Oncology and Hematology, AZ Turnhout, Turnhout, Belgium.
B PetitDepartment of Medical Oncology, Centre Hospitalier Jolimon, La Louvière, Belgium.
C LangenaekenDepartment of Medical Oncology, Iridium Cancer Network Antwerp, AZ Klina, Brasschaat, Belgium.
R Van RijswijkDepartment of Medical Oncology, ZNA Stuivenberg, Antwerp, Belgium.
P SpecenierDepartment of Medical Oncology, University Hospital Antwerp, Antwerp, Belgium.
G JerusalemDepartment of Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liege University, Liege, Belgium.
J P PraetDepartment of Geriatric Medicine, CHU St-Pierre, Free Universities Brussels, Brussels, Belgium.
K VandenborreDepartment of Medical Oncology, AZ Vesalius, Tongeren, Belgium.
M LyckeCancer Centre, General Hospital Groeninge, Kortrijk, Belgium & Positive Ageing Research Institute (PARI), Anglia Ruskin University, Chelmsford, UK.
J FlamaingDepartment of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
K MilisenDepartment of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium.
J P Lobelle, Beernem, Belgium.
H WildiersDepartment of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.

Funding

180211N Fonds voor Wetenschappelijk OnderzoekCancer Plan PC_24_A-025
6 · The paper itself

Abstract

purposeUsing the EORTC Global Health Status (GHS) scale, we aimed to determine minimal clinically important differences (MCID) in health-related quality of life (HRQOL) changes for older cancer patients with a geriatric risk profile, as defined by the geriatric 8 (G8) health screening tool, undergoing treatment. Simultaneously, we assessed baseline patient characteristics prognostic for HRQOL changes.

methodsOur analysis included 1424 (G8 ≤ 14) older patients with cancer scheduled to receive chemotherapy (n = 683) or surgery (n = 741). Anchor-based methods, linking the GHS score to clinical indicators, were used to determine MCID between baseline and follow-up at 3 months. A threshold of 0.2 standard deviation (SD) was used to exclude MCID estimates too small for interpretation. Logistic regressions analysed baseline patient characteristics prognostic for HRQOL changes.

resultsThe 15-item Geriatric Depression Scale (GDS15), Visual Analogue Scale (VAS) for Fatigue and ECOG Performance Status (PS) were selected as clinical anchors. In the surgery group, MCID estimates for improvement and deterioration were ECOG PS (5*, 11*), GDS15 (5*, 2) and VAS Fatigue (3, 9*). In the chemotherapy group, MCID estimates for improvement and deterioration were ECOG PS (8*, 7*), GDS15 (5, 4) and VAS Fatigue (5, 5*). Estimates with * were > 0.2 SD threshold. Patients experiencing pain or malnutrition (surgery group) or fatigue (chemotherapy group) at baseline showed a significantly stable or improved HRQOL (p < 0.05) after their treatment.

conclusionThe reported MCID for improvement and deterioration depended on the anchor used and treatment received. The estimates can be used to evaluate significant changes in HRQOL and to determine sample sizes in clinical trials.

Indexed as

Health StatusMinimal Clinically Important DifferenceAdultAgedAged, 80 and overAntineoplastic AgentsFemaleGeriatric AssessmentHumansMaleMiddle AgedNeoplasmsPainPain MeasurementQuality of LifeSurveys and QuestionnairesAntineoplastic AgentsCancerElderly patients with cancerGeriatric assessmentMinimal important differencesQuality of life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.